BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12419647)

  • 21. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
    Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
    J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective effect of ethanol on norepinephrine- and nicotine-induced emesis in cats.
    Beleslin DB; Jovanović-Mićić D; Nikolić SB; Samardzić R
    Alcohol; 1991; 8(6):499-501. PubMed ID: 1781927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiemetic effect of a tachykinin NK1 receptor antagonist GR205171 on cisplatin-induced early and delayed emesis in the pigeon.
    Tanihata S; Oda S; Kakuta S; Uchiyama T
    Eur J Pharmacol; 2003 Feb; 461(2-3):197-206. PubMed ID: 12586215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diphenidol has no actual broad antiemetic activity in dogs and ferrets.
    Nakayama H; Yamakuni H; Nakayama A; Maeda Y; Imazumi K; Matsuo M; Mutoh S
    J Pharmacol Sci; 2004 Nov; 96(3):301-6. PubMed ID: 15528840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The actions of fentanyl to inhibit drug-induced emesis.
    Barnes NM; Bunce KT; Naylor RJ; Rudd JA
    Neuropharmacology; 1991 Oct; 30(10):1073-83. PubMed ID: 1661861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.
    Massidda B; Ionta MT
    J Chemother; 1996 Jun; 8(3):237-42. PubMed ID: 8808724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin-induced emesis in the cat: effect of granisetron and dexamethasone.
    Rudd JA; Tse JY; Wai MK
    Eur J Pharmacol; 2000 Mar; 391(1-2):145-50. PubMed ID: 10720646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal control of cyclophosphamide-induced emesis.
    Stewart A
    Oncology; 1996 Jun; 53 Suppl 1():32-8. PubMed ID: 8692548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic effects of morphine on motion- and drug-induced emesis in Suncus murinus.
    Kakimoto S; Saito H; Matsuki N
    Biol Pharm Bull; 1997 Jul; 20(7):739-42. PubMed ID: 9255411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo assessment of antiemetic drugs and mechanism of lycorine-induced nausea and emesis.
    Kretzing S; Abraham G; Seiwert B; Ungemach FR; Krügel U; Teichert J; Regenthal R
    Arch Toxicol; 2011 Dec; 85(12):1565-73. PubMed ID: 21626407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
    J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, blinded, controlled trial of the antiemetic effect of ondansetron on dexmedetomidine-induced emesis in cats.
    Santos LC; Ludders JW; Erb HN; Martin-Flores M; Basher KL; Kirch P
    Vet Anaesth Analg; 2011 Jul; 38(4):320-7. PubMed ID: 21645198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of the simultaneous blockade of the dopamine D-2, histamine H-1, and muscarinic cholinergic receptors in cancer chemotherapy-induced emesis: results of a controlled trial.
    Martin-Jimenez M; Diaz-Rubio E
    Cancer Chemother Pharmacol; 1986; 18(2):168-71. PubMed ID: 2947734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide:
    Italian Group For Antiemetic Research
    J Clin Oncol; 2004 Feb; 22(4):725-9. PubMed ID: 14966097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
    Foss JF; Yuan CS; Roizen MF; Goldberg LI
    Cancer Chemother Pharmacol; 1998; 42(4):287-91. PubMed ID: 9744773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms by which cancer chemotherapeutic drugs induce emesis.
    Cubeddu LX
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):2-13. PubMed ID: 1485177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological agents affecting emesis. A review (Part I).
    Mitchelson F
    Drugs; 1992 Mar; 43(3):295-315. PubMed ID: 1374316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
    Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
    Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.